| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.9M | -25.0% |
| R&D Expense | $38.5M | +1.5% |
| SG&A Expense | $114.8M | +16.0% |
| Operating Income | -$116.2M | -72.3% |
| Interest Expense | $4.3M | +13.3% |
| Pre-tax Income | -$192.9M | -203.1% |
| Income Tax | -$2.8M | +36.0% |
| Net Income | -$190.1M | -220.9% |
| EPS (Basic) | -$2.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.3M | +185.8% |
| Short-term Investments | $84.5M | — |
| Accounts Receivable | $17.3M | -5.7% |
| Inventory | $21.5M | +3.1% |
| Current Assets | $208.8M | +189.8% |
| Total Assets | $390.3M | +41.8% |
| Current Liabilities | $43.4M | -12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.4M | -102.8% |
| Capital Expenditures | $3.8M | -71.2% |
| Investing Cash Flow | -$88.1M | -637.7% |
| Financing Cash Flow | $230.8M | +1345.9% |
| Free Cash Flow | -$93.2M | -62.6% |
| -211.5% |
| EPS (Diluted) | -$2.43 | -211.5% |
| Total Liabilities |
| $160.5M |
| -11.1% |
| Stockholders' Equity | -$81.5M | -186.1% |